On the HCPLive psoriatic arthritis page, resources on the topics of medical news and expert insight into PsA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on arthritis, and more.
May 17th 2024
An analysis of more than 1800 adults with psoriatic arthritis found more than 20% of patients report widespread pain, with 10% meeting fibromyalgia criteria.
Patients with Psoriatic Arthritis Tend to Quickly Modify or Abandon Initial Treatment
October 2nd 2014The majority of patients with psoriatic arthritis treated with disease-modifying antirheumatic drugs will switch medications, discontinue treatment, or add an additional medicine, usually within a few months of initiating treatment.
Oral Medication Option May Lead to Improved Treatment Adherence in Patients with Psoriatic Arthritis
September 4th 2014Until apremilast was approved earlier this year, patients with psoriatic arthritis had to rely primarily on injectable therapies, which contributed to less than optimal treatment adherence in many patients.
Apremilast and the Future of Psoriatic Arthritis Treatment
August 21st 2014When it was approved by the FDA in March 2014, apremilast became the first oral medication approved for the treatment of psoriatic arthritis (PsA). Data from clinical trials showed it to be an effective option for patients, with a safer side effect profile than currently used PsA treatments.
The National Psoriasis Foundation Announces Ambitious New Programs and Initiatives
August 21st 2014The National Psoriasis Foundation (NPF) recently announced a number of new programs and a five-year strategic mission for the organization with initiatives that are designed to increase research and uncover new treatments for all forms of psoriasis and psoriatic disease.
Targeting Inflammation in Diabetes through Disease-modifying Therapies
July 8th 2014An endocrinologist from the University Hospital Basel in Switzerland discusses the role of inflammation in the pathogenesis of type 2 diabetes, outlining the reasons why clinicians should target inflammation when treating diabetics.
Weight Loss Improves Disease Management in Patients with Psoriatic Arthritis
July 1st 2014Study results show that obese patients with psoriatic arthritis who were treated with tumor necrosis factor-alpha blockers who also lost at least 5 percent of their bodyweight from baseline were much more likely to achieve minimal disease activity.
Cardiovascular Risk Factors Associated with Psoriatic Arthritis Complicate Treatment Decisions
May 28th 2014Patients with psoriatic arthritis may be at increased risk for cardiovascular disease, so physicians must carefully weigh the pros and cons of treatment with corticosteroids and other proatherogenic drugs.
Underwater Inferential Current Therapy Improves Hand Psoriatic Arthritis
April 24th 2014Underwater inferential current therapy significantly improves overall hand function in patients whose psoriatic arthritis affects their hands, according to a study published in the April issue of International Journal of Physiotherapy and Research.